Pacira BioSciences, Inc. (PCRX), a company focused on non-opioid pain therapies, said on Monday that it has appointed Shawn Cross as Chief Financial Officer.
Prior to joining Pacira, Cross served at Applied Molecular Transport, Inc., or AMT, a developer of novel oral biological therapeutics to treat severe autoimmune, metabolic, and inflammatory diseases.
He initially served as AMT's CFO. Cross was subsequently promoted to the role of COO and later appointed as CEO to lead the company's merger with Cyclo Therapeutics, Inc. (CYTH), where he currently serves on the Board.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.